Latest Stories

You write us letters. We read them. Kai Ryssdal goes through some of your most recent comments on the student loan scandal, free trade, and the cost of flowers.

Some physicians are returning to old-fashioned, solo practices that allow them to spend more time with patients. Pat Loeb spent time with one doctor who's made the switch.

Today's annual report on the fiscal health of the Medicare system is expected to put forth a prognosis so bleak it will trigger the program's first-ever funding warning. And even that probably won't make a difference.

Bolivia's government has lost control of its populace. Demonstrators from rivaling provinces have forced work stoppages and taken to the streets in an ongoing battle over who gets what share of the nation's oil and gas revenue.

It's been a long time since federal prosecutors have lost a high-profile corporate fraud case. Newsweek's Allan Sloan says it's because government lawyers have finally learned to explain the situation in plain English.

A new study finds the disparity between what men and women earn in the workplace begins right out of college, and only gets worse as the years go by. New legislation could help close the gap.

AstraZeneca, which has been struggling to get new drugs to market, is looking to get into the biological medicines game. So it's going to pay $15.6 billion for MedImmune to make it happen.

Environmentally-conscious travelers will soon have the opportunity to put their money where their mouths are. Delta is going to offer passengers an option to pay a $5 to $11 surcharge per ticket to offset carbon emissions.

Almost. It's not a done deal yet, but Britain's Barclays is set to purchase Dutch bank ABN Amro for more than $90 billion. They've all but shut out rival bidders in what's to be the world's biggest bank buyout ever.